These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17316578)

  • 21. Detection of BBB disruption and hemorrhage by Gd-DTPA enhanced MRI after embolic stroke in rat.
    Ding G; Jiang Q; Li L; Zhang L; Gang Zhang Z; Ledbetter KA; Ewing JR; Li Q; Chopp M
    Brain Res; 2006 Oct; 1114(1):195-203. PubMed ID: 16950236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute changes of coagulation and fibrinolysis parameters after experimental thromboembolic stroke and thrombolytic therapy.
    Stehling F; Weber R; Ozcelik A; Bröcker M; Volbracht L; Diener HC; Busch E
    Neurosci Lett; 2008 Aug; 441(1):39-43. PubMed ID: 18597942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery.
    Kimura K; Iguchi Y; Shibazaki K; Aoki J; Terasawa Y
    J Neurol Sci; 2008 Sep; 272(1-2):136-42. PubMed ID: 18602647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
    Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of cerebral tissue by MRI map ISODATA in embolic stroke in rat.
    Ding G; Jiang Q; Li L; Zhang L; Zhang ZG; Soltanian-Zadeh H; Li Q; Whitton PA; Ewing JR; Chopp M
    Brain Res; 2006 Apr; 1084(1):202-9. PubMed ID: 16566903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
    Lapchak PA
    Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: synergism with tissue plasminogen activator.
    Lapchak PA
    Exp Neurol; 2007 Jun; 205(2):407-13. PubMed ID: 17439814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined systemic thrombolysis with alteplase and early hyperbaric oxygen therapy in experimental embolic stroke in rats: relationship to functional outcome and reduction of structural damage.
    Küppers-Tiedt L; Manaenko A; Michalski D; Guenther A; Hobohm C; Wagner A; Zhang JH; Schneider D
    Acta Neurochir Suppl; 2011; 111():167-72. PubMed ID: 21725750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator.
    Furuichi Y; Maeda M; Matsuoka N; Mutoh S; Yanagihara T
    Exp Neurol; 2007 Mar; 204(1):138-46. PubMed ID: 17169359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model.
    Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
    Scand J Clin Lab Invest; 1993 Jul; 53(4):383-93. PubMed ID: 8378742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infarct prediction and treatment assessment with MRI-based algorithms in experimental stroke models.
    Wu O; Sumii T; Asahi M; Sasamata M; Ostergaard L; Rosen BR; Lo EH; Dijkhuizen RM
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):196-204. PubMed ID: 16685257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
    J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.
    Tanaka Y; Marumo T; Omura T; Yoshida S
    Brain Res; 2007 Jun; 1154():194-9. PubMed ID: 17475227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Map-ISODATA demarcates regional response to combination rt-PA and 7E3 F(ab')2 treatment of embolic stroke in the rat.
    Li L; Jiang Q; Ding G; Zhang L; Zhang ZG; Ewing JR; Knight RA; Kapke A; Soltanian-Zadeh H; Chopp M
    J Magn Reson Imaging; 2005 Jun; 21(6):726-34. PubMed ID: 15906325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
    El Amki M; Lerouet D; Coqueran B; Curis E; Orset C; Vivien D; Plotkine M; Marchand-Leroux C; Margaill I
    Exp Neurol; 2012 Dec; 238(2):138-44. PubMed ID: 22921458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypointense transcerebral veins at T2*-weighted MRI: a marker of hemorrhagic transformation risk in patients treated with intravenous tissue plasminogen activator.
    Hermier M; Nighoghossian N; Derex L; Adeleine P; Wiart M; Berthezène Y; Cotton F; Pialat JB; Dardel P; Honnorat J; Trouillas P; Froment JC
    J Cereb Blood Flow Metab; 2003 Nov; 23(11):1362-70. PubMed ID: 14600444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.